ストックスクリーナーアプリを入手
4.43
4.73%
-0.22
アフターアワーズ：
4.44
0.01
+0.23%
前日終値:
$4.65
開ける：
$4.71
24時間の取引高:
817.48K
Relative Volume:
0.60
時価総額：
$301.43M
収益：
$69.23M
当期純損益:
$-33.10M
株価収益率:
-3.7542
EPS:
-1.18
ネットキャッシュフロー:
$-39.26M
1週間 パフォーマンス:
-3.28%
1か月 パフォーマンス:
+8.58%
6か月 パフォーマンス:
+278.63%
1年 パフォーマンス:
+77.91%
1日の値動き範囲:
$4.42
$4.75
1週間の範囲:
$3.30
$4.815
52週間の値動き範囲:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
STIM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
4.43 | 301.43M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 開始されました | BTIG Research | Buy |
| 2018-07-24 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Neuronetics Inc (STIM) 最新ニュース
Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83 - Yahoo Finance
Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22% - Investing.com Nigeria
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges - Yahoo Finance
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges By GuruFocus - Investing.com Canada
Neuronetics Reports Strong Q1 2025 Growth - TipRanks
Neuronetics: Q1 Earnings Snapshot - CTPost
Neuronetics Q1 2025 Earnings Call Transcript - MarketBeat
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025 - marketscreener.com
Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth - Investing.com Canada
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Neuronetics (STIM) Surpasses Q1 Revenue Expectations with $32M | - GuruFocus
Neuronetics Reports First Quarter 2025 Financial and Operating R - GuruFocus
Neuronetics Inc (STIM) Q1 2025 Earnings: Revenue Surpasses Estimates at $32.0M, EPS Misses at $(0.21) - GuruFocus
Neuronetics reports inducement grant - Medical Buyer
Neuronetics Announces CFO Retirement Amidst Q1 Growth - TipRanks
Neuronetics, Inc. SEC 10-Q Report - TradingView
Neuronetics Reports First Quarter 2025 Financial and Operating Results - The Manila Times
Renaissance Technologies LLC Has $255,000 Position in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
JPMorgan Chase & Co. Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5 - GuruFocus
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Transcranial Magnetic Stimulator Market Generated - openPR.com
Neuronetics, Inc.'s (NASDAQ:STIM) 30% Jump Shows Its Popularity With Investors - simplywall.st
Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category - IT Business Net
Geode Capital Management LLC Buys 8,466 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Taking the lead: Neuronetics Inc (STIM) - Sete News
Insider’s View: Deciphering Neuronetics Inc (STIM)’s Financial Health Through Ratios - DWinneX
Neuronetics Inc (STIM) stock on the rise: An overview - uspostnews.com
Why Neuronetics, Inc. (STIM) is Surging in 2025 - Insider Monkey
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer - The Malaysian Reserve
Neuronetics, Inc.'s (NASDAQ:STIM) market cap surged US$39m last week, individual investors who have a lot riding on the company were rewarded - simplywall.st
Neuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6 - MSN
Was there any good news for Neuronetics Inc (STIM) stock in the last session? - uspostnews.com
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call | STIM Stock News - GuruFocus
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times
Medical Tech Leader Neuronetics Sets Q1 2025 Earnings Release: Key Details for Neurohealth Investors - Stock Titan
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update - Defense World
Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN
Transcranial Magnetic Stimulator Market to Witness Remarkable - openPR.com
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
Even though Neuronetics (NASDAQ:STIM) has lost US$30m market cap in last 7 days, shareholders are still up 130% over 5 years - simplywall.st
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression - The Manila Times
Major Insurance Breakthrough: NeuroStar's Teen Depression Treatment Now Covered for 15 Million Lives - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (NASDAQ:STIM) - Seeking Alpha
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4 - Marketscreener.com
Neuronetics Inc (STIM) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.79%
大文字化:
|
ボリューム (24 時間):